Cargando…

Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance

While great strides have been made in the treatment of advanced renal cell carcinoma (RCC) with the emergence of immune checkpoint inhibitors (ICIs) and VEGFR-targeting drugs, sizable proportions of patients still do not respond to upfront therapy and long-term responses only occur in a minority of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schoenfeld, David A., Merkin, Ross D., Moutafi, Myrto, Martinez, Sandra, Adeniran, Adebowale, Kumar, Deepika, Jilaveanu, Lucia, Hurwitz, Michael, Rimm, David L., Kluger, Harriet M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608089/ https://www.ncbi.nlm.nih.gov/pubmed/36313654 http://dx.doi.org/10.3389/fonc.2022.990367

Ejemplares similares

Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases
por: Schoenfeld, David A, et al.
Publicado: (2023)

MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors
por: Shuch, Brian, et al.
Publicado: (2015)

Characterization of tumor infiltrating lymphocytes in paired primary and metastatic renal cell carcinoma specimens
por: Baine, Marina K., et al.
Publicado: (2015)

19. PLEKHA5 REGULATES TUMOR GROWTH IN METASTATIC MELANOMA
por: Oria, Victor, et al.
Publicado: (2020)

Vascularity of primary and metastatic renal cell carcinoma specimens
por: Aziz, Saadia A, et al.
Publicado: (2013)

Coupled fibromodulin and SOX2 signaling as a critical regulator of metastatic outgrowth in melanoma
por: Oria, Victor O., et al.
Publicado: (2022)

Expression of drug targets in primary and matched metastatic renal cell carcinoma tumors
por: Aziz, Saadia A, et al.
Publicado: (2013)

MEK targeting in N-RAS mutated metastatic melanoma
por: Thumar, Jaykumar, et al.
Publicado: (2014)

Melanoma brain metastases have lower T-cell content and microvessel density compared to matched extracranial metastases
por: Weiss, Sarah A., et al.
Publicado: (2020)

Differential PD-1/LAG-3 expression and immune phenotypes in metastatic sites of breast cancer
por: Sobottka, Bettina, et al.
Publicado: (2021)

The Impact of Primary Tumor Location in Synchronous Metastatic Colorectal Cancer: Differences in Metastatic Sites and Survival
por: Brouwer, Nelleke P. M., et al.
Publicado: (2019)

Nonregional Lymph Nodes as the Only Metastatic Site in Stage IV Esophageal Cancer
por: Zhan, Peter L., et al.
Publicado: (2022)

Quantitative analysis of CMTM6 expression in tumor microenvironment in metastatic melanoma and association with outcome on immunotherapy
por: Martinez-Morilla, Sandra, et al.
Publicado: (2020)

Bone Metastasis as the Only Metastatic Site in a Patient with Pancreatic Cancer following Distal Pancreatectomy
por: Saif, Muhammad Wasif, et al.
Publicado: (2010)

Melanocortin 1 receptor (MC1R) expression as a marker of progression in melanoma
por: Su, David, et al.
Publicado: (2023)

Standardization of PD-L1 immunohistochemistry
por: Martinez-Morilla, Sandra, et al.
Publicado: (2021)

Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma
por: Aziz, Saadia A, et al.
Publicado: (2014)

Multiplex quantitative analysis of cancer-associated fibroblasts and immunotherapy outcome in metastatic melanoma
por: Wong, Pok Fai, et al.
Publicado: (2019)

Comparison of programmed death-ligand 1 protein expression between primary and metastatic lesions in patients with lung cancer
por: Moutafi, Myrto K, et al.
Publicado: (2021)

A modified IL-18 drug in combination with CTLA-4 blockade enhances anti-tumor efficacy in preclinical models of renal cell carcinoma
por: Schoenfeld, David, et al.
Publicado: (2023)

A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better
por: Djureinovic, Dijana, et al.
Publicado: (2023)

Digital spatial profiling of melanoma shows CD95 expression in immune cells is associated with resistance to immunotherapy
por: Martinez-Morilla, Sandra, et al.
Publicado: (2023)

PD-L1 Expression in Clear Cell Renal Cell Carcinoma: An Analysis of Nephrectomy and Sites of Metastases
por: Jilaveanu, L.B., et al.
Publicado: (2014)

Germline genetic variants are associated with development of insulin-dependent diabetes in cancer patients treated with immune checkpoint inhibitors
por: Caulfield, Jasmine I, et al.
Publicado: (2023)

Drug targets and predictive biomarkers in the management of metastatic melanoma
por: Thumar, Jaykumar, et al.
Publicado: (2012)

Location, location: understanding the metastatic microenvironment
por: Erez, Neta
Publicado: (2023)

Rare Metastatic Sites of a Lung Adenocarcinoma
por: Soh, Rui Ya, et al.
Publicado: (2018)

Expression of NKX3.1, Prostatic Specific Antigen and Prostatic Specific Alkaline Phosphatase in Cytology Specimens of Metastatic Prostatic Carcinoma
por: Wang, Minhua, et al.
Publicado: (2021)

The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization
por: Kluger, Harriet M, et al.
Publicado: (2007)

[(11)C]Methionine and [(11)C]PBR28 as PET Imaging Tracers to Differentiate Metastatic Tumor Recurrence or Radiation Necrosis
por: Tran, Thuy T., et al.
Publicado: (2020)

Radiotherapy is Important for Local Control at Primary and Metastatic Sites in Pediatric Rhabdomyosarcoma
por: Skamene, Sonia, et al.
Publicado: (2015)

Tumor Homogeneity between Primary and Metastatic Sites for BRAF Status in Metastatic Melanoma Determined by Immunohistochemical and Molecular Testing
por: Boursault, Lucile, et al.
Publicado: (2013)

Risk factors and predictors for tumor site origin in metastatic adenocarcinoma of unknown primary site
por: Li, Xinrong, et al.
Publicado: (2021)

Typical and atypical metastatic sites of recurrent endometrial carcinoma
por: Kurra, Vikram, et al.
Publicado: (2013)

Metastatic Gastrointestinal Carcinoid Tumor with Unknown Primary Site
por: Liang, Peter S., et al.
Publicado: (2015)

Site-specific metabolic phenotypes in metastatic breast cancer
por: Kim, Hye Min, et al.
Publicado: (2014)

CT Perfusion Characteristics Identify Metastatic Sites in Liver
por: Wang, Yuan, et al.
Publicado: (2015)

Parotid Gland as Initial Metastatic Site of Nasopharyngeal Carcinoma
por: Wang, Yan, et al.
Publicado: (2016)

Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site
por: Selves, Janick, et al.
Publicado: (2018)

Prognosis of Patients With Testicular Carcinoma Is Dependent on Metastatic Site
por: Xu, Peihang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fkk8r1ek8825q7opr6p5cmfiui